Korean stocks could go nuclear

If the summit between the US and North Korea is successful and North Korea embarks on China or Vietnam-style liberalisation, South Korean stocks could scoop a “peace dividend”.

888_MW_P05_Markets_Side

Korea: the tempo is picking up
(Image credit: This content is subject to copyright.)

Korean stocks jumped by a quarter to a new record above 2,500 last year, and are expected to rise further. Korea is a geared play on global growth, given the country's dependence on exports, so the world economy's improvement over the past few months has been key. The constituents of the Kospi are expected to report almost $50bn of first-quarter earnings, eclipsing the previous record set in the third quarter of 2017.

Profits are set to expand by 17% in 2018, yet the market is on just 8.7 times this year's earnings, says Assif Shameen in Barron's. Chalk that up to the "Korea discount'" a reflection of poor corporate governance and low yields. But this may be changing: Korean firms are responding to investors' complaints and upping dividends, rather than focusing only on top-line growth.

And there's another reason to keep a close eye on Korea: a potential "peace dividend" if the summit between the US and North Korea is successful and North Korea embarks on China or Vietnam-style liberalisation. The south has "long eyed a vast market in the north with consumers demanding their first TVs, washing machines smartphones and cars".

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
Andrew Van Sickle

Andrew is the editor of MoneyWeek magazine. He grew up in Vienna and studied at the University of St Andrews, where he gained a first-class MA in geography & international relations.

After graduating he began to contribute to the foreign page of The Week and soon afterwards joined MoneyWeek at its inception in October 2000. He helped Merryn Somerset Webb establish it as Britain’s best-selling financial magazine, contributing to every section of the publication and specialising in macroeconomics and stockmarkets, before going part-time.

His freelance projects have included a 2009 relaunch of The Pharma Letter, where he covered corporate news and political developments in the German pharmaceuticals market for two years, and a multiyear stint as deputy editor of the Barclays account at Redwood, a marketing agency.

Andrew has been editing MoneyWeek since 2018, and continues to specialise in investment and news in German-speaking countries owing to his fluent command of the language.